SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis. 2006; 12: 641650.
  • 2
    Aberra FN, Lichtenstein GR. Methods to avoid infections in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11: 685695.
  • 3
    Viget N, Vernier-Massouille G, Salmon-Ceron D, et al. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut. 2008; 57: 549558.
  • 4
    Statistics Canada. Leading Causes of Death in Canada. Statistics Canada Catalogue number 84–215-XWE 2005. Available at: http://www40.statcan.gc.ca/l01/cst01/hlth36a-eng.htm. Accessed October 1 2010.
  • 5
    Schanzer DL, Tam TWS, Langley JM, et al. Influenza-attributable deaths, Canada 1990–1999. Epidemiol Infect. 2007; 135: 11091116.
  • 6
    Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003; 289: 179186.
  • 7
    Schanzer DL, Langley JM, Tam TWS. Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals. Influenza Other Respir Viruses. 2008; 2: 18.
  • 8
    Schanzer DLM, Langley JMM, Tam TWSM. Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children. Pediatr Infect Dis J. 2006; 25: 795800.
  • 9
    Kwong JC. Evaluation of the effect of Ontario's Universal Influenza Immunization Program (UIIP). Public Health Agency of Canada, Catalogue HP40–34/2008E-PDF 2008.
  • 10
    Billings JL, Hertz MI, Savik K, et al. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transpl. 2002; 21: 559566.
  • 11
    Hassan IA, Chopra R, Swindell R, et al. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience. Bone Marrow Transplant. 2003; 32: 7377.
  • 12
    Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med. 1997; 102: 29.
  • 13
    Statement on Seasonal Trivalent Inactivated Influenza Vaccine for 2010–2011. Can Commun Dis Rep. 2010; 36: 149. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/10vol36/acs-6/index-eng.php. Accessed October 1 2010.
  • 14
    Prevention and control of influenza with vaccines—2010–11 recommendations of the Advisory Committee on Immunization Practices. Available at: http://www.cdc.gov/flu/professionals/acip/index.htm. Accessed October 1 2010.
  • 15
    Fiore AE, Bridges CB, Cox NJ. Seasonal influenza vaccines. Curr Top Microbiol Immunol. 2009; 333: 4382.
  • 16
    Melmed GY, Ippoliti AF, Papadakis KA, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006; 101: 18341840.
    Direct Link:
  • 17
    North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn's disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007; 44: 653674.
  • 18
    Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19( suppl A): 536.
  • 19
    Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991; 12: 439447.
  • 20
    Hyams J, Markowitz J, Otley A, et al. Pediatric Inflammatory Bowel Disease Collaborative Research Group. Evaluation of the pediatric Crohn's disease activity index: a prospective multicenter experience. Pediatr Gastroenterol Nutr. 2005; 41: 416421.
  • 21
    Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007; 133: 423432.
  • 22
    Statement on Seasonal Trivalent Inactivated Influenza Vaccine for 2007–2008. Can Commun Dis Rep. 2007; 36: 138. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07vol33/acs-07/index-eng.php. Accessed October 1 2010.
  • 23
    Adverse Reactions. In: Vaccinations and Communicable Disease Control Manual. Calgary Health Region 2004: 113.
  • 24
    Kendal AP, Pereira MS, Shekel J. Concepts and procedures for laboratory-based influenza surveillance. Geneva: World Health Organization; 1982.
  • 25
    Beyer WE, Palache AM, de Jong JC, et al. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine. 2002; 20: 13401353.
  • 26
    Mamula P, Markowitz JE, Piccoli DA, et al. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 5: 851856.
  • 27
    Lu Y, Jacobson DL, Ashworth LA, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009; 104: 444453.
  • 28
    Mack DR, Chartrand SA, Ruby EI, et al. Influenza vaccination following liver transplantation in children. Liver Transpl Surg. 1996; 2: 431437.
  • 29
    Edvardsson VO, Flynn JT, Deforest A, et al. Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant. 1996; 10: 556560.
  • 30
    Mauch TJ, Crouch NA, Freese DK, et al. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr. 1995; 127: 957960.
  • 31
    Beyer WEP, Palache AM, Masuerl N, et al. Critical evaluation of parameters to assess the antibody response to influenza vaccination. In: Proceedings of the Abstract Book of the International Conference on Options for the Control of Influenza, Courchevel, 1992; 70.
  • 32
    Ruben FL. Inactivated influenza virus vaccines in children. Clin Infect Dis. 2004; 38: 678688.
  • 33
    Gelinck LB, van der Bijl AE, Beyer WE, et al. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis. 2008; 67: 713716.
  • 34
    Fomin I, Caspi D, Levy V, et al. Vaccination against influenza in rheumatoid arthritis: The effect of disease modifying drugs, including TNF a blockers. Ann Rheum Dis. 2006; 65: 191194.
  • 35
    Abu-Shakra M, Press J, Varsano N, et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol. 2002; 29: 25552557.
  • 36
    Holvast A, Huckriede A, Wilschut J, et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis. 2006; 65: 913918.
  • 37
    Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol. 2000; 61: 8593.
  • 38
    Stevens R, Oliver M, Brogan M, et al. Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients. Gastroenterology. 1985; 88: 18601866.
  • 39
    Brogan MD, Shanahan F, Oliver M, et al. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization. J Clin Lab Immunol. 1987; 24: 6974.
  • 40
    Kilhamn J, Brevinge H, Svennerholm AM, et al. Immune responses in ileostomy fluid and serum after oral cholera vaccination of patients colectomized because of ulcerative colitis. Infect Immun. 1998; 66: 39953999.
  • 41
    Kilhamn J, Lundin SB, Brevinge H, et al. T- and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccine. Clin Diagn Lab Immunol. 2003; 10: 426430.
  • 42
    Melmed GY, Agarwal N, Frenck RW, et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol. 2010; 105: 148154.
  • 43
    Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis. 2009; 15: 14101416.
  • 44
    Sands BE, Cuffari C, Katz J, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004; 10: 677692.
  • 45
    Lu Y, Jacobson D, Bousvaros A. Immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009; 15: 14171423.